Search research articles
Contact Us
Filters
Showing results (51-60 of 127) with videos related to
Page
of 13
Sort By:
Blood Cancer Journal
|
December 18, 2022
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation
Madlen Jentzsch, Lara Bischof, Jule Ussmann, et al.
Frontiers in Digital Health
|
January 4, 2024
A digital twin model for evidence-based clinical decision support in multiple myeloma treatment
Nora Grieb, Lukas Schmierer, Hyeon Ung Kim, et al.
The Lancet. Haematology
|
July 3, 2025
Virtual twins for personalised CAR T-cell therapy in myeloma
Kristin Reiche, Ulrike Weirauch, Markus Kreuz, et al.
Oncotarget
|
June 5, 2018
Volumetry based biomarker speed of growth: Quantifying the change of total tumor volume in whole-body magnetic resonance imaging over time improves risk stratification of smoldering multiple myeloma patients
Markus Wennmann, Laurent Kintzelé, Marie Piraud, et al.
Blood Cancer Journal
|
June 12, 2025
Sex-associated differences in outcome of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation
Jule Ussmann, Lara Bischof, Donata Backhaus, et al.
American Journal of Hematology
|
April 8, 2025
Impact of Evolving WHO and ICC Classifications on Prognosis and Outcomes in AML Patients Undergoing Allogeneic Stem Cell Transplantation
Jacob Jendro, Jule Ussmann, Dominic Brauer, et al.
Patient Preference and Adherence
|
April 22, 2025
Perspectives of Healthcare Providers and Patients with Relapsed/Refractory Multiple Myeloma on Treatment Priorities and Novel Therapies
Sikander Ailawadhi, Yelak Biru, Solène Clavreul, et al.
British Journal of Haematology
|
May 24, 2022
Whole-body magnetic resonance imaging plus serological follow-up for early identification of progression in smouldering myeloma patients to prevent development of end-organ damage
Markus Wennmann, Hartmut Goldschmidt, Jennifer Mosebach, et al.
Leukemia & Lymphoma
|
June 2, 2020
Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects
Lina Jansen, Maximilian Merz, Monika Engelhardt, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 21, 2025
Correction to: Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [<sup>18</sup>F]FDG PET/CT predicts survival in multiple myeloma
Christos Sachpekidis, Olof Enqvist, Johannes Ulén, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 127) with videos related to
Sort By:
Page
of 13
Blood Cancer Journal
|
December 18, 2022
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation
Madlen Jentzsch, Lara Bischof, Jule Ussmann, et al.
Frontiers in Digital Health
|
January 4, 2024
A digital twin model for evidence-based clinical decision support in multiple myeloma treatment
Nora Grieb, Lukas Schmierer, Hyeon Ung Kim, et al.
The Lancet. Haematology
|
July 3, 2025
Virtual twins for personalised CAR T-cell therapy in myeloma
Kristin Reiche, Ulrike Weirauch, Markus Kreuz, et al.
Oncotarget
|
June 5, 2018
Volumetry based biomarker speed of growth: Quantifying the change of total tumor volume in whole-body magnetic resonance imaging over time improves risk stratification of smoldering multiple myeloma patients
Markus Wennmann, Laurent Kintzelé, Marie Piraud, et al.
Blood Cancer Journal
|
June 12, 2025
Sex-associated differences in outcome of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation
Jule Ussmann, Lara Bischof, Donata Backhaus, et al.
American Journal of Hematology
|
April 8, 2025
Impact of Evolving WHO and ICC Classifications on Prognosis and Outcomes in AML Patients Undergoing Allogeneic Stem Cell Transplantation
Jacob Jendro, Jule Ussmann, Dominic Brauer, et al.
Patient Preference and Adherence
|
April 22, 2025
Perspectives of Healthcare Providers and Patients with Relapsed/Refractory Multiple Myeloma on Treatment Priorities and Novel Therapies
Sikander Ailawadhi, Yelak Biru, Solène Clavreul, et al.
British Journal of Haematology
|
May 24, 2022
Whole-body magnetic resonance imaging plus serological follow-up for early identification of progression in smouldering myeloma patients to prevent development of end-organ damage
Markus Wennmann, Hartmut Goldschmidt, Jennifer Mosebach, et al.
Leukemia & Lymphoma
|
June 2, 2020
Autologous stem cell transplantation in multiple myeloma patients: utilization patterns and hospital effects
Lina Jansen, Maximilian Merz, Monika Engelhardt, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 21, 2025
Correction to: Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [<sup>18</sup>F]FDG PET/CT predicts survival in multiple myeloma
Christos Sachpekidis, Olof Enqvist, Johannes Ulén, et al.
Page
of 13